CEACAM5 and cancer: Although used extensively for early diagnosis of cancers, carcinoembryonic antigen (CEA) [13] and carbohydrate antigen 19-9 (CA19-9) [13,182] have limitations in clinical practice and a single biopsy of tumor specimens is often not informative enough about tumor progression and metastasis [183].